CCK Stock Cash Flow Statements

Crown Quarterly Cash Flow Statements Chart

Quarterly

Annual

Stock-Based Compensation

Operating Cash Flow

Investing Cash Flow

Financing Cash Flow

Free Cash Flow

Capital Expenditure

Crown Quarterly Cash Flow Statements Table

Quarterly

Annual

Unit: USD	2025-06-30	2025-03-31	2024-12-31	2024-09-30	2024-06-30	2024-03-31	2023-12-31	2023-09-30	2023-06-30	2023-03-31	2022-12-31	2022-09-30	2022-06-30	2022-03-31	2021-12-31	2021-09-30	2021-06-30	2021-03-31	2020-12-31	2020-09-30	2020-06-30	2020-03-31	2019-12-31	2019-09-30	2019-06-30	2019-03-31	2018-12-31	2018-09-30	2018-06-30	2018-03-31	2017-12-31	2017-09-30	2017-06-30	2017-03-31	2016-06-30	2016-03-31	2015-09-30	2012-03-31	2009-12-31	2009-09-30	2008-12-31	2008-09-30

cash flows from operating activities
net income	216,000,000	227,000,000	392,000,000	-132,000,000	207,000,000	93,000,000		200,000,000	187,000,000	122,000,000		158,000,000	329,000,000	246,000,000		131,000,000	173,000,000	245,000,000	188,000,000	245,000,000	141,000,000	114,000,000	116,000,000	204,000,000	174,000,000	131,000,000	75,000,000	193,000,000	147,000,000	113,000,000	-61,000,000	208,000,000	148,000,000	133,000,000	185,000,000	99,000,000	160,000,000	90,000,000
adjustments to reconcile net income to net cash from operating activities:
depreciation and amortization	114,000,000	110,000,000	104,000,000	114,000,000	115,000,000	115,000,000	127,000,000	124,000,000	125,000,000	123,000,000	114,000,000	115,000,000	116,000,000	115,000,000	111,000,000	113,000,000	112,000,000	127,000,000	121,000,000	121,000,000	117,000,000	122,000,000	124,000,000	121,000,000	123,000,000	122,000,000	120,000,000	127,000,000	113,000,000	65,000,000	64,000,000	63,000,000	61,000,000	59,000,000	65,000,000	60,000,000	61,000,000	42,000,000
restructuring and other	47,000,000	-2,000,000	48,000,000	-13,000,000	17,000,000	23,000,000	82,000,000	15,000,000	6,000,000	11,000,000	23,000,000	-1,000,000	-73,000,000	-1,000,000	14,000,000	-17,000,000	-25,000,000	2,000,000	14,000,000	10,000,000	3,000,000	7,000,000	15,000,000	0	-45,000,000	4,000,000	16,000,000	-1,000,000	16,000,000	13,000,000	22,000,000	12,000,000	18,000,000	-4,000,000	-3,000,000	2,000,000	40,000,000
pension and postretirement expense	4,000,000	10,000,000	4,000,000	529,000,000	19,000,000	16,000,000
pension contributions	-3,000,000	25,000,000	0	-117,000,000	-9,000,000	4,000,000	-9,000,000	-6,000,000	-5,000,000	1,000,000	-2,000,000	22,000,000	13,000,000	20,000,000	51,000,000	-276,000,000	-6,000,000	-5,000,000	-11,000,000	-5,000,000	-6,000,000	-5,000,000	-9,000,000	-5,000,000	-2,000,000	-7,000,000	-6,000,000	-4,000,000	-5,000,000	-5,000,000	-248,000,000	-18,000,000	-15,000,000	-13,000,000	-16,000,000	-25,000,000	-20,000,000	-18,000,000
stock-based compensation	12,000,000	14,000,000	10,000,000	12,000,000	8,000,000	12,000,000	4,000,000	10,000,000	6,000,000	11,000,000	6,000,000	7,000,000	6,000,000	10,000,000	6,000,000	10,000,000	6,000,000	11,000,000	9,000,000	8,000,000	5,000,000	10,000,000	6,000,000	7,000,000	8,000,000	8,000,000	10,000,000	6,000,000	5,000,000	6,000,000	7,000,000	6,000,000	6,000,000	4,000,000	4,000,000	6,000,000	5,000,000	10,000,000
equity earnings, net of distributions				-6,000,000	6,000,000	2,000,000		-11,000,000	-7,000,000	27,000,000
working capital changes and other	59,000,000	-370,000,000		167,000,000	82,000,000	-367,000,000		192,000,000	196,000,000	-545,000,000		-379,000,000	98,000,000	-699,000,000		85,000,000	211,000,000	-777,000,000		157,000,000	83,000,000	-898,000,000
net cash from operating activities			295,000,000	554,000,000	445,000,000	-102,000,000	621,000,000	539,000,000	528,000,000	-235,000,000	669,000,000	-62,000,000	497,000,000	-301,000,000	660,000,000			-385,000,000	1,006,000,000	547,000,000	369,000,000	-607,000,000		428,000,000	439,000,000	-666,000,000		260,000,000	259,000,000	-751,000,000	272,000,000	456,000,000	352,000,000	-320,000,000	471,000,000	-408,000,000	330,000,000	-389,000,000			568,000,000	208,000,000
cash flows from investing activities
capital expenditures	-56,000,000	-33,000,000	-149,000,000	-76,000,000	-84,000,000	-94,000,000	-179,000,000	-160,000,000	-221,000,000	-233,000,000	-232,000,000	-297,000,000	-193,000,000	-117,000,000	-304,000,000	-187,000,000	-190,000,000	-135,000,000	-254,000,000	-134,000,000	-89,000,000	-110,000,000	-190,000,000	-88,000,000	-79,000,000	-75,000,000	-157,000,000	-105,000,000	-108,000,000	-92,000,000	-216,000,000	-82,000,000	-93,000,000	-107,000,000	-92,000,000	-51,000,000	-65,000,000	-62,000,000	-72,000,000	-33,000,000	-60,000,000	-43,000,000
free cash flows			146,000,000	478,000,000	361,000,000	-196,000,000	442,000,000	379,000,000	307,000,000	-468,000,000	437,000,000	-359,000,000	304,000,000	-418,000,000	356,000,000			-520,000,000	752,000,000	413,000,000	280,000,000	-717,000,000		340,000,000	360,000,000	-741,000,000		155,000,000	151,000,000	-843,000,000	56,000,000	374,000,000	259,000,000	-427,000,000	379,000,000	-459,000,000	265,000,000	-451,000,000			508,000,000	165,000,000
net investment hedge	0	13,000,000		12,000,000	0	13,000,000		12,000,000	0	13,000,000		13,000,000	0	13,000,000		12,000,000	0	13,000,000		13,000,000	1,000,000	14,000,000		15,000,000	0	6,000,000
proceeds from sale of property, plant and equipment	8,000,000	21,000,000	7,000,000	-1,000,000			12,000,000	3,000,000	1,000,000	1,000,000	0	0	3,000,000	12,000,000	20,000,000			2,000,000	8,000,000				22,000,000	6,000,000	6,000,000	5,000,000	9,000,000	22,000,000			0	3,000,000	2,000,000	3,000,000					0	1,000,000	5,000,000	4,000,000
other							53,000,000	3,000,000	3,000,000	2,000,000	-102,000,000	2,000,000	9,000,000	-8,000,000	-79,000,000	-2,000,000			61,000,000				59,000,000	-106,000,000	74,000,000	-49,000,000	-52,000,000	14,000,000	-6,000,000	16,000,000	-35,000,000	-12,000,000	29,000,000	7,000,000	9,000,000	-19,000,000	-11,000,000	-34,000,000	65,000,000		8,000,000	-3,000,000
net cash from investing activities			196,000,000	-65,000,000	-62,000,000	-81,000,000		-142,000,000	-217,000,000	-161,000,000			-13,000,000	-117,000,000			-191,000,000	-120,000,000	-226,000,000	-125,000,000	-88,000,000	-96,000,000		-79,000,000	-73,000,000	-64,000,000		73,000,000	-3,850,000,000	58,000,000	-220,000,000	-99,000,000	-86,000,000	-104,000,000	-77,000,000	-48,000,000	-72,000,000	-48,000,000	-90,000,000	-32,000,000	-58,000,000	-42,000,000
cash flows from financing activities
net change in revolving credit facility and short-term debt	7,000,000	1,000,000					-36,000,000	-51,000,000	-642,000,000	331,000,000	-147,000,000	293,000,000	-36,000,000	158,000,000	47,000,000	5,000,000	-27,000,000	-13,000,000	-13,000,000	-141,000,000	-689,000,000	872,000,000	-141,000,000	-304,000,000	-296,000,000	731,000,000	-42,000,000	-228,000,000	-375,000,000	576,000,000	73,000,000	-227,000,000	-102,000,000	351,000,000	-245,000,000	383,000,000	-62,000,000	338,000,000	75,000,000	22,000,000	-197,000,000	-116,000,000
proceeds from short-term debt	75,000,000	177,000,000	66,000,000	32,000,000	44,000,000	80,000,000
payments of short-term debt	-83,000,000	-43,000,000	-84,000,000	-37,000,000	-36,000,000	-8,000,000
proceeds from long-term debt			0	655,000,000	0	20,000,000	538,000,000	20,000,000			-1,000,000	2,351,000,000	2,000,000	601,000,000	64,000,000	45,000,000	-1,000,000	36,000,000	-3,000,000	2,000,000	18,000,000	93,000,000					0	0	2,170,000,000	1,912,000,000	0	1,000,000	1,049,000,000	4,000,000	1,000,000	303,000,000	14,000,000	21,000,000	1,000,000	3,000,000
payments of long-term debt	-890,000,000	-27,000,000	-1,038,000,000	-690,000,000	-28,000,000	-32,000,000	-232,000,000	-40,000,000	-16,000,000	-24,000,000	-15,000,000	-2,188,000,000	-33,000,000	-42,000,000	-1,770,000,000	-28,000,000	-10,000,000	-26,000,000	-206,000,000	-22,000,000	-29,000,000	-12,000,000	-2,522,000,000	-18,000,000	-24,000,000	-281,000,000	-277,000,000	-19,000,000	-24,000,000	-13,000,000	-37,000,000	3,000,000	-1,091,000,000	-12,000,000	-16,000,000	-709,000,000	-28,000,000	-8,000,000	-467,000,000		-27,000,000	-8,000,000
debt issuance costs			0				-8,000,000				0
dividends paid to noncontrolling interests	-34,000,000	-28,000,000	-74,000,000	-5,000,000	-25,000,000	-15,000,000	-82,000,000	-33,000,000	0	-11,000,000	-66,000,000	-10,000,000	-13,000,000	-11,000,000	-66,000,000	-32,000,000	-15,000,000	-9,000,000	-44,000,000	-31,000,000	-1,000,000	-11,000,000	-65,000,000	-25,000,000	-2,000,000	-9,000,000	-42,000,000	-12,000,000			-25,000,000	-31,000,000	-24,000,000	-13,000,000	-18,000,000	-8,000,000	-4,000,000	-16,000,000	-34,000,000	-26,000,000
dividends paid to shareholders	-30,000,000	-30,000,000	-29,000,000	-30,000,000	-30,000,000	-30,000,000	-29,000,000	-29,000,000	-28,000,000	-29,000,000	-26,000,000	-27,000,000	-26,000,000	-27,000,000	-26,000,000	-26,000,000	-26,000,000	-27,000,000
common stock repurchased	-6,000,000	-203,000,000	-100,000,000	-110,000,000	-2,000,000	-5,000,000	0	-1,000,000	-5,000,000	-6,000,000	0	-122,000,000	-250,000,000	-350,000,000	-205,000,000	-448,000,000	-285,000,000	-12,000,000	-8,000,000	0	-1,000,000	-57,000,000	-5,000,000	0	-1,000,000	-1,000,000	0	0	-3,000,000	-1,000,000	0	-62,000,000	-144,000,000	-133,000,000	-4,000,000	-4,000,000	0	-7,000,000
net cash from financing activities						9,000,000				262,000,000											-686,000,000	882,000,000		-344,000,000	-318,000,000	417,000,000		-260,000,000	1,707,000,000	2,455,000,000		-289,000,000	-310,000,000	199,000,000			-68,000,000	338,000,000
effect of exchange rate changes on cash, cash equivalents and restricted cash	29,000,000	1,000,000	-42,000,000	23,000,000	-11,000,000	-8,000,000	10,000,000	-2,000,000	-9,000,000	-3,000,000	5,000,000	0	-59,000,000	-36,000,000	-79,000,000	-25,000,000	2,000,000	-11,000,000	35,000,000	9,000,000	11,000,000	-21,000,000	2,000,000	-4,000,000	1,000,000	2,000,000	-5,000,000	-26,000,000	-20,000,000	14,000,000
net change in cash, cash equivalents and restricted cash	159,000,000	-137,000,000	-817,000,000	322,000,000	293,000,000	-182,000,000	498,000,000	259,000,000	141,000,000	-137,000,000	187,000,000	-74,000,000	66,000,000	-133,000,000	-1,734,000,000	1,663,000,000	-3,000,000	-571,000,000	550,000,000	261,000,000	-394,000,000	158,000,000	265,000,000	1,000,000	49,000,000	-311,000,000	305,000,000	47,000,000	-1,904,000,000	1,776,000,000
cash, cash equivalents and restricted cash at january 1	0	1,016,000,000	0	0	0	1,400,000,000	0	0	0	639,000,000	0	0	0	593,000,000	0	0	0	1,238,000,000	0	0	0	663,000,000	0	0	0	659,000,000	0	0	0	435,000,000
cash, cash equivalents and restricted cash at june 30
net cash from / (used for) operating activities		14,000,000
net cash from / (used for) investing activities		1,000,000													-284,000,000
net cash from / (used for) financing activities		-153,000,000												321,000,000
cash, cash equivalents and restricted cash at march 31		879,000,000				1,218,000,000				502,000,000				460,000,000				667,000,000								348,000,000				2,211,000,000
gain on sale of equity method investment
deferred income taxes																							-98,000,000				-29,000,000				187,000,000
asbestos payments
changes in assets and liabilities:
receivables																							314,000,000	-26,000,000	-137,000,000	-91,000,000	462,000,000	-296,000,000	-295,000,000	-364,000,000	86,000,000	-102,000,000	-80,000,000	-36,000,000	91,000,000	-93,000,000	-105,000,000	-114,000,000
inventories																							146,000,000	64,000,000	22,000,000	-171,000,000	-62,000,000	91,000,000	-61,000,000	-169,000,000	43,000,000	76,000,000	-33,000,000	-151,000,000	-36,000,000	-180,000,000	122,000,000	-140,000,000
accounts payable and accrued liabilities																							256,000,000	90,000,000	179,000,000	-612,000,000	246,000,000	75,000,000	333,000,000	-445,000,000	205,000,000	160,000,000	212,000,000	-324,000,000	165,000,000	-265,000,000	74,000,000	-249,000,000
prepaids and other assets
proceeds from sale of businesses, net of cash
acquisitions of businesses, net of cash
net investment hedges
distribution from equity method investment							12,000,000	0	0	56,000,000
net cash (used for) / provided by financing activities																-490,000,000	-368,000,000	-55,000,000
cash, cash equivalents and restricted cash at december 31
cash, cash equivalents and restricted cash at september 30
net income /
income from disposal of discontinued operations
income from early extinguishments of debt
net cash (used for) / provided by investing activities											-230,000,000
premiums paid to retire debt											0
foreign exchange derivatives related to debt									0	2,000,000	-3,000,000	-4,000,000			-12,000,000	-5,000,000	-4,000,000	-4,000,000	9,000,000	23,000,000	16,000,000	-5,000,000	-7,000,000	1,000,000	1,000,000	-11,000,000	-8,000,000	-1,000,000	-15,000,000	10,000,000	-11,000,000	27,000,000	16,000,000	-5,000,000	0	32,000,000	10,000,000
loss on debt extinguishment
pension expense								15,000,000	20,000,000	15,000,000		5,000,000	8,000,000	8,000,000	1,531,000,000	11,000,000	13,000,000	12,000,000	12,000,000	11,000,000	26,000,000	43,000,000	14,000,000	12,000,000			37,000,000	5,000,000	2,000,000	1,000,000	2,000,000	3,000,000	6,000,000	5,000,000	7,000,000	7,000,000	13,000,000	24,000,000
proceeds from sale of businesses, net of cash received												0
acquisition of businesses, net of cash acquired												0
payments of finance leases								-1,000,000	0	-1,000,000		-1,000,000	0	-1,000,000		-1,000,000	0	-1,000,000		-1,000,000	0	-1,000,000		-1,000,000	0	-14,000,000
common stock issued												0			1,000,000	0	0	1,000,000	1,000,000	0	0	1,000,000	0	1,000,000	1,000,000	2,000,000	0	0			1,000,000	0	1,000,000	7,000,000	4,000,000	1,000,000	0	2,000,000	14,000,000	5,000,000	0	3,000,000
bond issuance costs													0	-7,000,000
net cash from / (used) for financing activities
proceeds from sale of business, net of cash
acquisitions of business, net of cash
loss on sale of discontinued businesses
loss on classification as held for sale
acquisition of business, net of cash acquired														-23,000,000														-5,000,000
proceeds from sale of discontinued operations, net of cash disposed														6,000,000	0
net (loss) / income
adjustments to reconcile net (loss) / income to net cash from operating activities:
goodwill impairment
finance lease payments
contribution from noncontrolling interests
contributions from noncontrolling interests																				0	0	2,000,000		2,000,000
beneficial interest in transferred receivables
foreign exchange derivatives related to acquisition
cash, cash equivalents and restricted cash at march																						821,000,000
adjustments to reconcile net income to net cash from / (used for) operating activities:
foreign exchange																								4,000,000	1,000,000	1,000,000		-14,000,000	10,000,000	18,000,000
beneficial interests in transferred receivables																												155,000,000	160,000,000	175,000,000
foreign exchange derivatives related to acquisitions																												0
debt issue costs																												0	-41,000,000	-29,000,000		0			0	-2,000,000	-1,000,000
cash, cash equivalents and restricted cash at september
pension (benefit) / expense																										-2,000,000
foreign exchange derivatives related to an acquisition																														-25,000,000
proceeds from sale of businesses, net of cash sold
net investment hedge settlements
effect of exchange rate changes on cash and cash equivalents																															-2,000,000	5,000,000	7,000,000	4,000,000			-12,000,000	7,000,000	0	1,000,000
net change in cash and cash equivalents																															50,000,000	73,000,000	-37,000,000	-221,000,000	113,000,000	-460,000,000	178,000,000	-92,000,000	21,000,000	-268,000,000	264,000,000	21,000,000
cash and cash equivalents at january 1																															0	0	0	559,000,000	0	717,000,000	0	342,000,000	0	0	0	0
cash and cash equivalents at december 31
cash and cash equivalents at september 30
cash and cash equivalents at june 30
cash and cash equivalents at march 31																																		338,000,000		257,000,000		250,000,000
purchase of noncontrolling interests
net cash provided by/(used for) financing activities
purchase of business																																					0
proceeds from sale of business																																					3,000,000
net cash from by financing activities
net cash (used for)/provided by financing activities																																				-4,000,000
insurance proceeds																																						23,000,000
benefit from restructuring
asset impairments and sales
asbestos liabilities
acquisition of business
net cash provided by/(used for) operating activities
benefit from asset impairments and loss/gain on sale of assets
minority interests
changes in assets and liabilities, net of effect of divested businesses:
dividends paid to minority interests																																									-22,000,000	-16,000,000
net income/
adjustments to reconcile net income/(loss) to net cash provided by/(used for) operating activities:
(gain)/income from translation and foreign exchange
write-off of deferred financing fees...note t
minority interests and equity earnings
proceeds from sale of businesses, net of cash sold...note b
net cash provided by/(used for) investing activities
loss/(gain) from translation and foreign exchange
changes in assets and liabilities net of effect of divested businesses:
other assets and liabilities
funding of restricted cash accounts...note t
withdrawals from restricted cash accounts...note t
proceeds from sale of business, net of cash sold...note b
net change in short-term debt
net payment from termination of cross-currency swaps
adjustments to reconcile net income/(loss) to net cash from operating activities:
cumulative effect of a change in accounting
loss/(gain) from early extinguishments of debt
funding of restricted cash accounts...note r
withdrawals from restricted cash accounts...note r
proceeds from sale of businesses
dividends paid to minority interests, net of contributions
adjustments to reconcile net income to
net cash from operating activities:
benefit from asset impairments and loss/gain
on sale of assets
sale of assets
asbestos
net cash provided by/
investing activities
repayment of shareholder notes
dividends paid to minority interests, net of contributions .
effect of exchange rate changes on cash
and cash equivalents
benefit from asbestos
asbestos-related payments
benefit from asset impairments and loss/gain on
gain from early extinguishments of debt
changes in assets and liabilities, net of
businesses acquired:
new term loan borrowing
stock repurchased
dividends paid
acquisition of minority interests
minority contributions, net of dividends paid
financing activities

We provide you with 20 years of cash flow statements for Crown stock, allowing you to gain comprehensive visibility into the fundamentals of the company. Our detailed breakdowns include key financial metrics such as operating cash flows, cash levels, capital expenditures, profits, stock-based compensations and profit margins. This in-depth information is essential for making informed investment decisions and understanding the financial health and performance of Crown stock. Explore the full financial landscape of Crown stock with our expertly curated income statements.

The information provided in this report about Crown stock is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.